wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34105064-1FA8FC15-F93F-42E5-849B-1AA57ECFD324
Q34105064-1FA8FC15-F93F-42E5-849B-1AA57ECFD324
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34105064-1FA8FC15-F93F-42E5-849B-1AA57ECFD324
Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes.
P2860
Q34105064-1FA8FC15-F93F-42E5-849B-1AA57ECFD324
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34105064-1FA8FC15-F93F-42E5-849B-1AA57ECFD324
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7277a771468bdcf656c621a138dc6a36a9788efd
P2860
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.